{rfName}
Pe

Indexed in

License and use

Citations

3

Altmetrics

Analysis of institutional authors

Raimundo Andrés CañasAuthor

Share

Publications
>
Article

Perfil clínico de los pacientes tratados con evolocumab en unidades de lípidos/medicina interna en España. Estudio observacional (RETOSS-IMU)

Publicated to:Clinica e Investigacion en Arteriosclerosis. 32 (5): 183-192 - 2020-01-01 32(5), DOI: https://doi.org/10.1016/j.arteri.2020.02.003

Authors: Masana Marín, Lluís; López Miranda, José; Civeira Murillo, Fernando; Reinares García, Leonardo; Guijarro Herráiz, Carlos; Plana Gil, Núria; Cuenca, Rafael; Sánchez Fuentes, Demetrio; Hernández, José Luis; Andrés Cañas, Raimundo; Blanco Echevarría, Agustín; Villamayor, Santiago

Affiliations

Abstract

Objetivo Describir las características clínicas, las razones del inicio de la terapia y los efectos del tratamiento en la fase inicial de disponibilidad de evolocumab en las unidades de lípidos/medicina interna de España.

Keywords

arteriosclerotic cardiovascular diseaseenfermedad cardiovascular arterioscleróticaevolocumabfamilial hypercholesterolaemiahipercolesterolemia familiarldl-clipid unit/internal medicineunidades de lípidos/medicina internaCldl

Quality index

Bibliometric impact. Analysis of the contribution and dissemination channel

The work has been published in the journal Clinica e Investigacion en Arteriosclerosis, Q3 Agency Scopus (SJR), its regional focus and specialization in Pharmacology (Medical), give it significant recognition in a specific niche of scientific knowledge at an international level.

Independientemente del impacto esperado determinado por el canal de difusión, es importante destacar el impacto real observado de la propia aportación.

Según las diferentes agencias de indexación, el número de citas acumuladas por esta publicación hasta la fecha 2025-06-29:

  • Scopus: 3

Impact and social visibility

From the perspective of influence or social adoption, and based on metrics associated with mentions and interactions provided by agencies specializing in calculating the so-called "Alternative or Social Metrics," we can highlight as of 2025-06-29:

  • The use of this contribution in bookmarks, code forks, additions to favorite lists for recurrent reading, as well as general views, indicates that someone is using the publication as a basis for their current work. This may be a notable indicator of future more formal and academic citations. This claim is supported by the result of the "Capture" indicator, which yields a total of: 33 (PlumX).